Search results for "slas europe 2018"
Selected Filters:
Ribbon Bio progresses the field of synthetic DNA
Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules
How well are your HCP ELISAs covered?
Discover the strengths and weaknesses of one of the most common types of coverage assay
Developing safe and effective serial killers of solid tumors
Tackling a problem from the monomers up: How can we create plastics from renewable sources?
We speak with Niklas Warlin to learn about his research into plastics made from renewable sources and how researchers are developing the monomers to build these
Shimadzu's new preparative chromatography systems promises high-performance purification
The Nexera Prep HPLC series and Nexera UC Prep are designed to address the challenges of pharmaceutical industries
Potential of whole genome sequencing to enable personalized cancer treatment
Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer
Streamlined Clinical Mass Spectrometry Workflow at Imperial College Healthcare
An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust
The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection
Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections
Rxi® Technology for Accurate Trace-Level Analysis and New EZGC™ Software from Restek
New SureCycler 8800 from Agilent Technologies
Leveraging ZEISS Airyscan to Integrate Subcellular and Structural Detail with Inscopix Functional Neural Network Data
Expanding freely behaving microscopy by delivering increased resolution, signal-to-noise and optical sectioning through data correlation
AACC Announces Largest Ever Clinical Lab Expo
Using NovaSeq 6000 for Ultra-High Throughput Sequencing
Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina
Minoryx Therapeutics Announces Dosing of First Patient in ADVANCE Trial, a Phase 2/3 Clinical Study of MIN-102 in Patients with Adrenomyeloneuropathy (AMN)
ADVANCE trial expected to initiate patient recruitment shortly in several other EU countries, followed by the US